Due to the moderate sensitivity of RNAScope compared to IHC, RNAScope identifies a population of cases across NSCLC, HNSCC and UC as PD-L1 high that would not be PD-L1 high by IHC. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.